Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

metronidazole injection, USP Principal Display Panel

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4456

100 mL
NDC 0409-7811-31

METRONIDazole
Injection, USP
500 mg/100 mL (5 mg/mL)

EACH mL CONTAINS METRONIDAZOLE 5 mg;
SODIUM CHLORIDE 7.9 mg; DIBASIC SODIUM
PHOSPHATE, ANHYDROUS 0.48 mg; CITRIC ACID,
ANHYDROUS 0.23 mg. SODIUM 14 mEq/100 mL.
314 mOsmol/LITER (CALC.). pH 5.8 (4.5 to 7.0).

ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.

DO NOT REFRIGERATE

SINGLE-DOSE CONTAINER. FOR INTRAVENOUS USE.
USUAL DOSAGE: SEE INSERT. STERILE, NONPYROGENIC.
PROTECT FROM LIGHT. USE ONLY IF SOLUTION IS CLEAR
AND CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.

RX ONLY

DISTRIBUTED BY HOSPIRA, INC.,
LAKE FOREST,
IL 60045 USA

3

V
CONTAINS DEHP

IM-4456
14480101

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4456

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0585

TO OPEN – TEAR AT NOTCH

NDC 0409-7811-31
One Unit

METRONIDazole
Injection, USP

Rx only

500 mg/100 mL (5 mg/mL)

Each mL contains metronidazole 5 mg; sodium chloride 7.9 mg; dibasic sodium
phosphate, anhydrous 0.48 mg; citric acid, anhydrous 0.23 mg. Sodium 14 mEq/100 mL.
314 mOsmol/liter (CALC.). pH 5.8 (4.5 to 7.0).

ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION

DO NOT REFRIGERATE

Single-dose container. For intravenous use. Usual dose: See insert. Sterile, nonpyrogenic.
Protect from light. Use only if solution is clear. After removing the overwrap, check
for minute leaks by squeezing container firmly. If leaks are found, discard unit as
sterility may be impaired. Must not be used in series connections.

The overwrap is a moisture barrier. Do not remove unit from overwrap until ready for
use. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to 77°F). [See
USP Controlled Room Temperature.] Protect from freezing. See insert.

F WR-0585

Hospira

Not Made With Natural Rubber Latex

14480201

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0585

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4457

100 mL
NDC 0409-7811-11

METRONIDazole
Injection, USP
500 mg/100 mL (5 mg/mL)

EACH mL CONTAINS METRONIDAZOLE 5 mg;
SODIUM CHLORIDE 7.9 mg; DIBASIC SODIUM
PHOSPHATE, ANHYDROUS 0.48 mg; CITRIC ACID,
ANHYDROUS 0.23 mg. SODIUM 14 mEq/100 mL.
314 mOsmol/LITER (CALC.). pH 5.8 (4.5 to 7.0).

ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.

DO NOT REFRIGERATE

SINGLE-DOSE CONTAINER. FOR INTRAVENOUS USE.
USUAL DOSAGE: SEE INSERT. STERILE, NONPYROGENIC.
PROTECT FROM LIGHT. USE ONLY IF SOLUTION IS CLEAR
AND CONTAINER IS UNDAMAGED. MUST
NOT BE USED IN SERIES CONNECTIONS.

RX ONLY

DISTRIBUTED BY HOSPIRA, INC.,
LAKE FOREST,
IL 60045 USA

3

V
CONTAINS DEHP

IM-4457
14479801

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Label - IM-4457

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0586

TO OPEN — TEAR AT NOTCH

NDC 0409-7811-32
Contains Four Units of NDC 0409-7811-11

METRONIDazole
Injection, USP

Rx only

500 mg/100 mL (5 mg/mL)

Each mL contains metronidazole 5 mg; sodium chloride 7.9 mg; dibasic sodium
phosphate, anhydrous 0.48 mg; citric acid, anhydrous 0.23 mg. Sodium 14 mEq/100 mL.
314 mOsmol/liter (CALC.). pH 5.8 (4.5 to 7.0).

ADDITIVES SHOULD NOT BE MADE TO THIS SOLUTION.

DO NOT REFRIGERATE

Single-dose container. For intravenous use. Usual dose: See insert. Sterile,
nonpyrogenic. Protect from light. Use only if solution is clear. After removing
the overwrap, check for minute leaks by squeezing container firmly. If leaks are
found, discard unit as sterility may be impaired. Must not be used in series
connections.

The overwrap is a moisture barrier. Do not remove unit from overwrap until ready
for use. Use unit promptly when pouch is opened. Store at 20 to 25°C (68 to 77°F).
[See USP Controlled Room Temperature.] Protect from freezing. See insert.

Not Made With Natural Rubber Latex
Distributed by Hospira, Inc.,
Lake Forest, IL 60045 USA

F WR-0586

Hospira

14479901

PRINCIPAL DISPLAY PANEL - 5 mg/mL Bag Pouch - WR-0586
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event